Podcast – The Near-Term Future Of Exosome Science

Dr. Linda Marbán, Ph.D., CEO of Capricor Therapeutics, a clinical-stage biotech focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases, joins Cell & Gene: The Podcast’s Erin Harris to discuss the current state and the near-term future of exosomes. Marbán discusses Capricor’s exosome program and the company’s proprietary allogeneic cardiosphere-derived cells (CDCs) and engineered exosomes. She also covers the company’s HOPE clinical trial series’ progress to treat Duchenne muscular dystrophy (DMD).

Sourcecell & gene.com

Leave a Reply

Your email address will not be published. Required fields are marked *